The
Transfusion News email arrived in my in-box this morning. I was rather
intrigued by the articles on massive transfusions and trauma, but I wasn’t
entirely sure about the ADAMS antibody/antigen stuff.
Low ADAMTS13 antigen and high ADAMTS13 antibody levels associated with mortality in TTP patients
![]()
August 1, 2017
While thrombotic thrombocytopenic purpura (TTP) has a mortality rate of approximately 10% even when treated, predictors of mortality are unknown. In a prospective cohort registry of 292 TTP patients with 312 episodes of TTP in the United Kingdom, factors associated with mortality were evaluated. TTP patients with high amounts (top quartile) of a disintegrin and [Read More]
While thrombotic thrombocytopenic purpura (TTP) has a mortality rate of approximately 10% even when treated, predictors of mortality are unknown. In a prospective cohort registry of 292 TTP patients with 312 episodes of TTP in the United Kingdom, factors associated with mortality were evaluated. TTP patients with high amounts (top quartile) of a disintegrin and [Read More]
Systematic Review Recommends Standard Ratios of Blood Products for Massive Transfusion
Observational studies have suggested that higher ratios of plasma and platelets to red blood cells (RBCs) might lead to better outcomes for severely bleeding patients requiring massive transfusions. Researchers recently performed a systematic review of the literature in order to determine if a 1:1:1 ratio of plasma, platelets and RBCs decreased morbidity and mortality compared [Read More]
Group A Plasma in Trauma with Nancy Dunbar & Tait Stevens
![]()
August 5, 2017 | BBGuy Podcast
Transfusion News has joined forces with Blood Bank Guy to bring you the best possible Transfusion Medicine educational content and current news.
Transfusion News has joined forces with Blood Bank Guy to bring you the best possible Transfusion Medicine educational content and current news.
No comments:
Post a Comment